Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?

By Braud A.C.   Asselain B.   Scholl S.   De La Rochefordiere   Palangie T.   Dieras V.   Pierga J.Y.   Dorval T.   Jouve M.   Beuzeboc P.   Pouillart P.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 392-397

Elsevier

Access to resources Recommend Favorite

Soluble Interleukin-6 Receptor is a Prognostic Marker for Relapse-Free Survival in Estrogen Receptor-Positive Breast Cancer

By Won Hye Sung   Kim Young Ae   Lee Jun Sang   Jeon Eun Kyoung   An Ho Jung   Sun Der Sheng   Ko Yoon Ho   Kim Jeong Soo  

Cancer Investigation, Vol. 31, Iss. 8, 2013-10 ,pp. : 516-521

Informa Healthcare

Access to resources Recommend Favorite

Primary docetaxel chemotherapy in patients with breast cancer: impact on response and survival

By Heys Steven  

Breast Cancer Research and Treatment, Vol. 90, Iss. 2, 2005-03 ,pp. : 169-185

Springer Publishing Company

Access to resources Recommend Favorite

Patterns of Local and Distant Disease Relapse in Patients with Breast Cancer Treated with Primary Chemotherapy: Do Patients with a Complete Pathological Response Differ from Those with Residual Tumour in the Breast?

By Chaturvedi Shailesh  

Breast Cancer Research and Treatment, Vol. 93, Iss. 2, 2005-09 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer - the role of clinical response

By Pierga J.-Y.   Mouret E.   Laurence V.   Dieras V.   Savigioni A.   Beuzeboc P.   Dorval T.   Palangie T.   Jouve M.   Pouillart P.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1089-1096

Elsevier

Access to resources Recommend Favorite